Commentary: Mendelian randomization and women's health

Jenny C Censin^{1

2}, Jonas Bovijn^{1

2}, Michael V Holmes^{1

3

4

5}, Cecilia M Lindgren^{1

2

5

6}

Affiliations

¹ Big Data Institute at the Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK.
² Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
³ Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
⁴ Medical Research Council Population Health Research Unit (MRC PHRU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
⁵ National Institute for Health Research Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.
⁶ Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA.

PMID: 31292646
PMCID: PMC6659371
DOI: 10.1093/ije/dyz141

Comment

Commentary: Mendelian randomization and women's health

Jenny C Censin et al. Int J Epidemiol. 2019.

. 2019 Jun 1;48(3):830-833.

doi: 10.1093/ije/dyz141.

Authors

Jenny C Censin^{1

2}, Jonas Bovijn^{1

2}, Michael V Holmes^{1

3

4

5}, Cecilia M Lindgren^{1

2

5

6}

Affiliations

¹ Big Data Institute at the Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK.
² Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
³ Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
⁴ Medical Research Council Population Health Research Unit (MRC PHRU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
⁵ National Institute for Health Research Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.
⁶ Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA.

PMID: 31292646
PMCID: PMC6659371
DOI: 10.1093/ije/dyz141

No abstract available

PubMed Disclaimer

Comment on

Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis.
Shu X, Wu L, Khankari NK, Shu XO, Wang TJ, Michailidou K, Bolla MK, Wang Q, Dennis J, Milne RL, Schmidt MK, Pharoah PDP, Andrulis IL, Hunter DJ, Simard J, Easton DF, Zheng W; Breast Cancer Association Consortium. Shu X, et al. Int J Epidemiol. 2019 Jun 1;48(3):795-806. doi: 10.1093/ije/dyy201. Int J Epidemiol. 2019. PMID: 30277539 Free PMC article.
Sex hormone binding globulin and risk of breast cancer: a Mendelian randomization study.
Dimou NL, Papadimitriou N, Gill D, Christakoudi S, Murphy N, Gunter MJ, Travis RC, Key TJ, Fortner RT, Haycock PC, Lewis SJ, Muir K, Martin RM, Tsilidis KK. Dimou NL, et al. Int J Epidemiol. 2019 Jun 1;48(3):807-816. doi: 10.1093/ije/dyz107. Int J Epidemiol. 2019. PMID: 31143958 Free PMC article.
Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study.
Harris HR, Cushing-Haugen KL, Webb PM, Nagle CM, Jordan SJ; Australian Ovarian Cancer Study Group; Risch HA, Rossing MA, Doherty JA, Goodman MT, Modugno F, Ness RB, Moysich KB, Kjær SK, Høgdall E, Jensen A, Schildkraut JM, Berchuck A, Cramer DW, Bandera EV, Rodriguez L, Wentzensen N, Kotsopoulos J, Narod SA, McLaughlin JR, Anton-Culver H, Ziogas A, Pearce CL, Wu AH, Lindström S, Terry KL. Harris HR, et al. Int J Epidemiol. 2019 Jun 1;48(3):822-830. doi: 10.1093/ije/dyz113. Int J Epidemiol. 2019. PMID: 31211375 Free PMC article.

References

1. Liu KA, Mager N.. Women’s involvement in clinical trials: historical perspective and future implications. Pharm Pract (Granada) 2016;14:708.. - PMC - PubMed
1. Ober C, Loisel DA, Gilad Y.. Sex-specific genetic architecture of human disease. Nat Rev Genet 2008;9:911–22. - PMC - PubMed
1. Doyal L. Sex, gender, and health: the need for a new approach. BMJ 2001;323:1061–63. - PMC - PubMed
1. McCartney CR, Marshall JC, Clinical P.. Polycystic Ovary Syndrome. N Engl J Med 2016;375:54–64. - PMC - PubMed
1. Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO.. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 2016;31:2841–55. - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Commentary: Mendelian randomization and women's health

Affiliations

Commentary: Mendelian randomization and women's health

Authors

Affiliations

Comment on

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical